Navigation Links
Hisamitsu Pharmaceutical Announces Two New FDA Approved Over-The-Counter Pain Relief Patches

TORRANCE, Calif., May 24 /PRNewswire/ -- Hisamitsu, a world leader in the manufacture of external pain relieving drugs, announced the release of two products for the American market—SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN.


Both SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN are the first and only FDA approved over-the-counter pain relief patches on the market today.  

SALONPAS® PAIN RELIEF PATCH/SALONPAS® ARTHRITIS PAIN patches are formulated for the temporary relief of the mild to moderate aches and pains of the muscles and joints associated with arthritis, sprains, strains, bruises and simple backaches experienced by patients age 18 or older.  The patches are ideally suited for seniors, workers, athletes and others. New SALONPAS® patches are effective for up to 12 hours, which contrasts with competing brands that are viable only up to 8 hours.

To introduce SALONPAS® patches, Hisamitsu will distribute over 2 million free samples.  Consumers may acquire them by visiting People can also join SALONPAS® Facebook page and follow SALONPAS® on Twitter.

Joining SALONPAS® Facebook page also allows individuals to engage with the community of SALONPAS users and provide resources on pain relief and pain prevention at home, the office or on the athletic field.  

SALONPAS® patches are the smarter way to relieve pain because they are safe, long lasting. Because they are patches, they go directly to the source of pain. Originally developed in Japan, SALONPAS® analgesic patches have proven safe and effective in clinical trials.  Each patch contains 10% methyl salicylate and 3% I-menthol as the active pharmaceutical ingredients. They also offer an alternative for people who have a difficulty swallowing such as children or the elderly.  

SALONPAS® patches are available at major drug stores and big box outlets such as Rite Aid, CVS Pharmacy, Walgreens, Duane Reade, and others. Suggested retail price is $7.99.

SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN are the latest offering from Hisamitsu Pharmaceutical, a Japan based company founded in 1847. Hisamitsu introduced the original SALONPAS® patch in 1934 and their products are sold in approximately fifty countries around the world.

For more information visit

SOURCE Hisamitsu America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
2. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
3. Epix Pharmaceuticals, Inc. Announces a Change in the May 28, 2010 Auction Sale of Epix Imaging Agents to June 22, 2010
4. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
5. Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference
6. Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 46th American Society of Clinical Oncology Annual Meeting
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Renhuang Pharmaceuticals Exhibits All-Natural Products at the 107th China Import and Export Fair
9. DOAR Provides Trial Consulting Services in Victory for 5,600 Women in Gender Discrimination Class Action Trial Against Pharmaceutical Giant
10. WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals
11. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Post Your Comments:
(Date:11/30/2015)... KONG, Nov. 30, 2015 (HK$,000)For the Six Months Ended 30 September 2015 ... Income , 421,979 , 384,242 , ... , 34,719 , (18.3) Medical Insurance ... , 16.1 Medical Devices and Accessories Sales , ... Chinese Herbal Medicines Sales , 2,822 , ...
(Date:11/30/2015)... Calif. , Nov. 30, 2015 /PRNewswire/ ... the norm in U.S. medical imaging is ... increasingly popular accountable care payer-provider contracts are ... and, in their wake, alter provider-vendor relationships. ... payments will push forward new purchasing frameworks ...
(Date:11/30/2015)... Nov. 30, 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... the development of oral drug delivery systems, announced today ... at up to $50,000,000 with Hefei Tianhui Incubator of Technologies Co., Ltd. ... capsule, ORMD-0801, in China , ... . The agreements were signed at the Israel ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... November 30, 2015 , ... ... continuing education course in Dallas, TX, on January 29 and 30, 2016. The ... improve the functions of their practices, to learn how to better succeed in ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... a key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus ... Georgia State University. , Their study showed that small molecule analogs that target ...
(Date:11/30/2015)... ... November 30, 2015 , ... Dr. Seth D. Margulies ... locations, patients can visit Dr. Margulies to experience the best available orthodontic experience in ... title of "NJ Top Dentist"! , Orthodontics is the branch of dentistry that specializes ...
(Date:11/30/2015)... ... 2015 , ... ”Dying Words: The AIDS Reporting of Jeff Schmalz and How ... coincide with World AIDS Day. The multi-media project will be in audio documentary form ... he was dying of the disease. , A collaborative effort led by author, professor ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Reports magazine, quoted Michael Hansen, Ph.D., a senior scientist at Consumer Reports as ... more so for a child’s exposure limits. , The original Nov 2015 CR ...
Breaking Medicine News(10 mins):